Research Studies

This page provides people living with mental illness, their families, and mental health researchers with an opportunity to connect in mental health research studies.

NAMI-NYC does not endorse any study on this page. Information is provided purely as a public service.

A group wishing to post on this page must submit their current IRB approval for the study, in addition to a written synopsis of your study answering the following:

  • A title
  • A brief description of the study.
  • Is the study therapeutic (offering treatment) or non-therapeutic?
  • Is the study funded? If yes, provide source of all funding; e.g., non-profit organization, governmental agency, or for-profit corporation including any ties to the pharmaceutical industry.
  • Who will be conducting the study? E.g. non-profit, government, hospital, or for-profit corporation, including any companies that run clinical trials.
  • Will subjects be paid? Include payment schedule and amount.

Current Studies

May 2018: Seeking patients with major depressive disorder (MDD) between the ages of 18 and 65 to participate in a new depression research study

A Double-Blind, Placebo-Controlled Study of Brexpiprazole plus Ketamine in Treatment-Resistant Depression (TRD)

Montefiore Medical Center is seeking patients with major depressive disorder (MDD) between the ages of 18 and 65 to participate in a new depression research study.

Dr. Jonathan Alpert is conducting this research to assess if the combination of brexpiprazole and intranasal ketamine can safely and effectively treat depression symptoms when added to stable, ongoing antidepressant treatment.  Ketamine is approved by the U.S. Food and Drug Administration (FDA) to be used with other drugs for anesthesia and as a pain reliever during procedures.  However, ketamine is not approved by the FDA to treat depression.  Brexpiprazole (Rexulti) is approved by the U.S. Food and Drug Administration (FDA) as an add-on treatment to an antidepressant medication to treat adults with major depressive disorder (MDD).  Participants will receive either the active study medication (1/2 chance of receiving brexiprazole) plus 40 mg of ketamine administered intranasally ,  or placebo (1/2 chance of receiving placebo) plus 40 mg of ketamine administered intranasally.  Participants will be monitored by an experienced study physician.  The study requires 12 visits to our research clinic over a period of 5 to 8 weeks, depending on the length of the screening portion.

Participants will receive compensation for their time.  You will be paid $450 if you complete the study.  If you do not complete the study, you will be paid for each visit you complete.

Please contact Jennifer Alexander if you or someone you know is interested in learning more about this study.

Jennifer Alexander

February 2018: Well-being among adult siblings of individuals with a mental/ developmental disability

The aim of this study is to measure well-being among non-disabled adult siblings of individuals with a mental disability. Previous research shows that some siblings have higher levels of well-being than others, based on different factors that are related to it, such as gender. I am interested to see if other factors are also related to well-being. As part of my Master’s in Clinical Psychology in England, I am conducting a study (thesis) and will be glad if you answer my online questionnaire. Participation takes approximately 5 minutes and is anonymous.

I am interested in the well-being of adult siblings of individuals with any mental or developmental disability. Further information can be found at the link below.

So ***if you are an adult sibling (18 years or older) and you are NOT diagnosed with ANY mental or developmental disability*** please take part in the survey by clicking here:

You can withdraw from the study at any stage by closing the browser. In case you have completed the study and still wish to withdraw, you will be asked to type a memorable code which will enable me to exclude you from the study. In such a case, please contact me via email noting your withdrawal.


Participation will take approximately 5 minutes.

December 2017: Does your child struggle to stay organized?

Does your child struggle to stay organized?

Many children with conditions like Attention-Deficit/Hyperactivity Disorder (ADHD) struggle to stay organized, manage their time, and plan activities. Even when ADHD is being well treated, organizational problems can cause difficulties in school and create headaches at home.

Children in grades 3-5 (who have one main teacher) are being recruited for a therapeutic study on brain function at the NYU Child Study Center funded by the National Institute of Mental Health.

Children must show difficulty with organization, time management or planning.

The study will include

  • a brief no-cost assessment
  • two brain MRI scans at NYU
  • a no-cost weekly individualized treatment for 12 weeks

Participants will be compensated $75 for the initial evaluation and $75 for each of the two MRI scan sessions.

For more information, please contact us at (646) 754-5147 or, or visit our website:

September 2017: First Episode Psychosis Research Study

The Schizophrenia Research Program at NYU Langone Health, is currently seeking individuals (ages 16-30) with a diagnosis of schizophrenia, schizotypal, or schizophreniform disorder who have not taken antipsychotic medication for at least 4 weeks to participate in our research study funded by the National Institute of Mental Health.

In our study, we are looking for an alternative treatment for individuals with early psychosis. We are trying to see if a single dose of an anticonvulsant medication may be able to quiet down a specific part of the brain.

The study involves:

  • Two study visits
  • Two brain imaging scans
  • One single dose of Keppra (an FDA approved anticonvulsant medication) or placebo.

If eligibility criteria are met, participants will receive $200 for the completion of the study in addition to reimbursement for travel. If you are interested in participating or want more information please call or text our study team at (917) 565-1581 or email us at

August 2017: A qualitative study that explores the lived experience of trauma survivors who have experienced misdiagnosis

Announcing a research project exploring the experiences of individuals who report a history of exposure to trauma but in the past did not receive a diagnosis that reflected recognition of their trauma-related reactions.

If you have been exposed to a traumatic event (such as the loss of a loved one or domestic violence), sought help from a mental health practitioner, and were not accurately diagnosed for trauma reactions, please consider participating in this study. You will have the opportunity to share how being wrongly diagnosed impacted you. Taking part in this study may lead to greater understanding of experiences, which could help develop future policies and programs to assist in accurately diagnosing individuals exposed to trauma and inform appropriate services.

I am a social worker and doctoral candidate at Adelphi University working on this research as a requirement for my degree. If you take part in this study, we will arrange to meet at a day and time that is convenient for you. We will also arrange to meet in a public place, such as the Manhattan Center at Adelphi University or a different public location that you are comfortable with. Everything you share will be kept confidential. Participation will include three separate interviews, 60-90 minutes each, for a total of 4-5 hours. At the end of the last interview session, we will take 1-2 hours to review the transcripts.

Participants must be 18 years or older. There will be no compensation for your participation.

If you are interested in participating in this study, or if you have any questions and would like more information, please contact Lisa Henshaw, LCSW at or call (516) 316-6845.

June 2017: Brain Imaging Study of Hearing Voices

We are seeking patients living with schizophrenia (ages 18-55) to participate in an imaging study investigating the mechanisms underlying auditory hallucinations in psychosis.

  • The study involves non-invasive MRI scans, computer tasks, and interviews at the New York State Psychiatric Institute, in New York City.
  • Earn up to $450 (partly depending on task performance) plus travel costs.
  • For more information, call 646-774-8137, or email

May 2017: Schizophrenia & Bipolar Research Study

We are looking for young adults 18-30 years old who have been diagnosed with schizophrenia, schizoaffective disorder, or bipolar disorder. You may be eligible to participate in a MRI research study that aims to understand the biology of schizophrenia disorder and bipolar disorder and their relation to cognition. We’re also looking for siblings.

  • Young adults (18-30 years old) with a diagnosis of schizophrenia or schizoaffective disorder.
  • Young adults (18-30 years old) with a diagnosis of bipolar disorder who have also had the experience of hearing or seeing things that other can’t, or having beliefs that others don’t agree with.
  • The sibling of a young adult who has been diagnosed with schizophrenia, schizoaffective disorder, or bipolar disorder and who has also had the experience of hearing or seeing things that other can’t, or having beliefs that others don’t agree with.

The study involves no treatment or modification of current treatment.

You will be compensated for your participation in the study.

If you are interested in participating please contact our coordinator at: or 212-263-3945 for more information.